Nanobiotix Statistics

Total Valuation

Nanobiotix has a market cap or net worth of $340.61 million. The enterprise value is $313.75 million.

Market Cap	340.61M
Enterprise Value	313.75M

Important Dates

The last earnings date was Wednesday, April 24, 2024, after market close.

Earnings Date	Apr 24, 2024
Ex-Dividend Date	n/a

Share Statistics

Nanobiotix has 47.11 million shares outstanding. The number of shares has increased by 1.16% in one year.

Shares Outstanding	47.11M
Shares Change (YoY)	+1.16%
Shares Change (QoQ)	+1.02%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	19.76%
Float	22.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	48.31
PS Ratio	8.47
Forward PS	10.09
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	7.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.75

Current Ratio	1.75
Quick Ratio	1.53
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.67

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-51.70%
Return on Capital (ROIC)	-54.96%
Revenue Per Employee	$394,412
Profits Per Employee	-$432,462
Employee Count	102
Asset Turnover	0.47
Inventory Turnover	n/a

Taxes

In the past 12 months, Nanobiotix has paid $130,434 in taxes.

Income Tax	130,434
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.60% in the last 52 weeks. The beta is 1.26, so Nanobiotix's price volatility has been higher than the market average.

Beta (1Y)	1.26
52-Week Price Change	+44.60%
50-Day Moving Average	6.28
200-Day Moving Average	7.07
Relative Strength Index (RSI)	67.34
Average Volume (30 Days)	30,017

Short Selling Information

Short Interest	55,685
Short Previous Month	52,704
Short % of Shares Out	0.12%
Short % of Float	0.24%
Short Ratio (days to cover)	0.67

Income Statement

In the last 12 months, Nanobiotix had revenue of $40.23 million and -$44.11 million in losses. Loss per share was -$1.17.

Revenue	40.23M
Gross Profit	39.36M
Operating Income	-29.11M
Pretax Income	-43.02M
Net Income	-44.11M
EBITDA	-25.29M
EBIT	-26.93M
Loss Per Share	-$1.17

Full Income Statement

Balance Sheet

The company has $81.83 million in cash and $54.96 million in debt, giving a net cash position of $26.87 million or $0.57 per share.

Cash & Cash Equivalents	81.83M
Total Debt	54.96M
Net Cash	26.87M
Net Cash Per Share	$0.57
Equity / Book Value	-2.00M
Book Value Per Share	-0.04
Working Capital	40.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$13.56 million and capital expenditures -$366,301, giving a free cash flow of -$13.93 million.

Operating Cash Flow	-13.56M
Capital Expenditures	-366,301
Free Cash Flow	-13.93M
FCF Per Share	-$0.40

Full Cash Flow Statement

Margins

Gross margin is 97.83%, with operating and profit margins of -72.35% and -109.65%.

Gross Margin	97.83%
Operating Margin	-72.35%
Pretax Margin	-106.94%
Profit Margin	-109.65%
EBITDA Margin	-62.86%
EBIT Margin	-66.94%
FCF Margin	-34.62%

Dividends & Yields

Nanobiotix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.16%
Shareholder Yield	-1.16%
Earnings Yield	-12.95%
FCF Yield	-4.09%

Analyst Forecast

The average price target for Nanobiotix is $11.00, which is 52.14% higher than the current price. The consensus rating is "Buy".

Price Target	$11.00
Price Target Difference	52.14%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	25.00%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nanobiotix has an Altman Z-Score of -2.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.75
Piotroski F-Score	3